Ledger.Open graph →
SEC Form D · filed April 29, 2015

Jounce Therapeutics, Inc

Offering
$56.0M
Sold
$56.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Cary G. Pfeffer · Cambridge, MADirectorRobert G. Tepper · Cambridge, MADirectorKim C. Drapkin · Cambridge, MAExecAnna L. Barry · Cambridge, MAExecRichard Murray · Albuquerque, NMExec · DirectorRobert G. Kamen · Cambridge, MADirectorRobert G. Tepper · Cambridge, MADirectorKim C. Drapkin · Cambridge, MAExecAnna L. Barry · Cambridge, MAExecRichard Murray · Cambridge, MAExec · DirectorCary G. Pfeffer · Cambridge, MADirectorRobert G. Kamen · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗